Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone | Zendy

José M. RuizMoreno | Zendy

Open Access

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone

Author(s) -

José M. RuizMoreno

Publication year - 2008

Publication title -

clinical ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.025

H-Index - 56

eISSN - 1177-5483

pISSN - 1177-5467

DOI - 10.2147/opth.s1643

Subject(s) - verteporfin , macular degeneration , photodynamic therapy , medicine , choroidal neovascularization , triamcinolone acetonide , ophthalmology , visual acuity , blindness , bevacizumab , surgery , dermatology , optometry , chemotherapy , chemistry , organic chemistry

Choroidal neovascularization (CNV) secondary to age related macular degeneration is among the leading causes of legal blindness in developed countries. Photodynamic therapy (PDT) with verteporfin induces CNV closure causing little damage to healthy tissue, but the need to re-treat may lead to low final visual acuity at an unacceptable cost. The association of intravitreous triamcinolone or antiangiogenic drugs with PDT has been used in order to reduce these limitations of the therapy. The combination of PDT and intravitreous triamcinolone, its complications and outcome at one and two-year follow-up are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research